By Rishika Sadam and Bhanvi Satija (Reuters) -Japanese drugmaker Takeda Pharmaceutical is exploring the option of conducting ...

NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), and a clinical stage, leading global ...

Several oncology companies announced key trial milestones this week across the landscape of both blood cancers and solid ...

Private equity firm THL Partners has agreed to buy a majority stake in Headlands Research, a U.S.-based network of clinical ...

Synthetic generation replicates key clinical patterns from real-world data, enabling valid analyses with fewer patients.

Vascular toxicity associated with cancer therapies is a leading cause of cardiovascular adverse events in patients with ...

A new vaccine aimed at a common cancer gene mutation could help stop aggressive pancreatic cancers from coming back, a small ...

H LUNDBECK A/S (($HLUYY)) announced an update on their ongoing clinical study. H. Lundbeck A/S is currently conducting a clinical trial titled ...

The reporting methods of noninferiority randomized clinical trials are often inconsistent, with many publications omitting ...

In this episode presented by Cresset, BioSpace’s head of insights Lori Ellis discusses clinical trial fail rates and AI’s ...

More than two years after the Food and Drug Administration held a public workshop on measuring overall survival (OS) in ...

While smoking rates in the United States have substantially declined over the past six decades, smoking remains high among ...